Novavax H-1B Visa Sponsorship 2026
Pharma & biotech ยท H-1B sponsor ยท FY2017โ2026
๐ข Gaithersburg, MD HQ๐ novavax.com
Does Novavax sponsor H-1B visas and green cards?
Yes. Novavax has filed 117 H-1B LCAs and 27 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025โ2026 Novavax filed 15 H-1B LCAs at a median base salary of $144,395, about 18% above the national H-1B median of $121,966 for the same period, and 12 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 3 | $146k |
| FY2025 | 12 | $136k |
| FY2024 | 16 | $135k |
| FY2023 | 17 | $149k |
| FY2022 | 19 | $115k |
| FY2021 | 24 | $108k |
| FY2020 | 2 | $101k |
| FY2019 | 8 | $82k |
| FY2018 | 12 | $83k |
| FY2017 | 4 | $68k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1Statistical Programmer III5$125k
- 2Associate Director,Safety Surveillance Global Vaccine Safety4$165k
- 3Scientist I4$83k
- 4Senior Data Engineer4$137k
- 5IT, Sales Distribution and Supply Chain Business Analyst3$125k
- 6Manager, Regulatory Affairs CMC3$135k
- 7Quality Assurance Engineer IV, Enterprise Computer Systems3$108k
- 8Senior Manager, GVS Systems3$164k
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year โ
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 3 | $134k |
| FY2025 | 9 | $136k |
| FY2024 | 7 | $125k |
| FY2023 | 3 | $145k |
| FY2019 | 2 | $73k |
| FY2018 | 3 | $98k |
Green-card route and outcomes
Worker backgrounds ยท FY2017โ2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 66
- US patents
- Published, not yet granted
- 80
- applications
- Most recent grant
- December 9, 2025
- Top area
- Preparations for medical46
Pay against the local market
Novavaxโs 10 most-filed occupations and metros, FY2018โFY2026. Its median base salary is 104% of the local BLS median for the same work.
| Occupation | Metro | Filings | Novavax pay | Local BLS medianโก | vs market |
|---|---|---|---|---|---|
| Biochemists and Biophysicists | Washington, DC | 13 | $86,161 | $97,076 | 89% |
| Computer Occupations, All Other | Washington, DC | 12 | $144,304 | $125,444 | 115% |
| Managers, All Other | Washington, DC | 10 | $155,400 | $157,864 | 98% |
| Biological Scientists, All Other | Washington, DC | 9 | $96,026 | $105,506 | 91% |
| Chemical Engineers | Washington, DC | 6 | $108,591 | $116,772 | 93% |
| Biological Technicians | Washington, DC | 5 | $77,084 | $59,726 | 129% |
| Medical Scientists | Washington, DC | 3 | $224,329 | $109,407 | 205% |
| Computer Occupations, All Other | Chicago, IL | 3 | $110,378 | $100,542 | 110% |
| Statisticians | Washington, DC | 3 | $113,282 | $115,517 | 98% |
| Industrial Engineers | Washington, DC | 3 | $110,005 | $104,213 | 106% |
About Novavax
Novavax is a pharma & biotech company based in Gaithersburg, MD. It was founded in 1987. It is listed on Nasdaq as NVAX.
- Name (DOL filings)
- Novavax
- Listed
- Nasdaq: NVAX
- Incorporated in
- Delaware
- Headquarters
- 21 Firstfield Rd, Gaithersburg, MD
- Industry
- Pharma & biotech
- Employees (US, est)
- 767 (2024)
- Revenue FY2025
- $1.1B +65% from $682M
- Net income FY2025
- $440M +335% from $-187M
- R&D FY2025
- $342M (30% of revenue)
Novavax pays a median H-1B base of $115,000 across FY2017โ2026, about 7% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Novavax
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Fresenius Kabi | 162 | 21 | $120k | 2 | โ |
| Ginkgo Bioworks | 161 | 19 | $112k | 5 | โ |
| Piramal | 158 | 19 | $88k | 6 | โ |
| Novavax | 117 | 15 | $144k | 2 | โ |
| Arcus Biosciences | 114 | 22 | $150k | 5 | 62% |
| Amyris | 113 | 13 | $105k | 6 | โ |
| Legend Biotech | 113 | 53 | $115k | 24 | 31% |
